It is also worth mentioning that, although a lower level of IGF-I is associated with a lower cancer risk in prospective healthy population, several studies have shown that lower IGF-I is associated with an increased risk of cardiovascular disease, type II diabetes, obesity [56, 66], osteoporosis, and cognitive decline [56]. This evidence concerns the gene IGF1 and cardiovascular disorder.